Filter
917
Filtered Results: 917
Text search:
medicine
manufacturing
Featured
Recommendations
78
New Publications
217
Language
Document type
No document type
411
Studies & Reports
207
Guidelines
147
Strategic & Response Plan
54
Manuals
50
Fact sheets
24
Situation Updates
9
Training Material
7
Resource Platforms
4
Brochures
2
Infographics
1
Videos
1
Countries / Regions
India
41
Global
38
Kenya
35
Nigeria
24
Uganda
23
Ethiopia
21
Ghana
20
Africa
16
Western and Central Europe
16
South Africa
16
Tanzania
15
Nepal
13
Zambia
13
Sierra Leone
12
Rwanda
12
Bangladesh
12
Lesotho
10
Philippines
10
South–East Asia Region
9
Malawi
8
West and Central Africa
8
East and Southern Africa
8
Liberia
8
Myanmar / Burma
8
Ukraine
7
Syria
7
Zimbabwe
7
Latin America and the Carribbean
7
Namibia
7
Botswana
7
Eastern Europe
5
Indonesia
5
Thailand
4
USA
4
Haiti
4
Cambodia
4
Congo, Democratic Republic of
4
Eswatini/ Swaziland
4
Cameroon
3
Albania
3
Asia
3
Moldova
3
Sri Lanka
3
Russia
3
South Sudan
3
Pakistan
3
Tajikistan
2
Benin
2
China
2
Laos
2
Senegal
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Mauritius
2
United Kingdom
2
Sudan
2
Yemen
2
Serbia
1
Australia
1
Afghanistan
1
Mongolia
1
Jordan
1
Germany
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Brazil
1
Egypt
1
Angola
1
Chad
1
Iraq
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
342
Clinical Guidelines
72
Public Health
41
Pharmacy & Technologies
34
Key Resources
31
Women & Child Health
15
Capacity Building
6
Toolboxes
COVID-19
106
Pharmacy
93
AMR
91
HIV
58
Planetary Health
46
TB
36
Mental Health
30
NTDs
25
Rapid Response
23
Global Health Education
17
NCDs
16
Health Financing Toolbox
15
Ebola & Marburg
14
Disability
13
Conflict
13
Specific Hazards
10
Caregiver
8
Natural Hazards
7
Refugee
4
Cholera
3
Malaria
1
Zika
1
Polio
1
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Accessed: 22.03.2019
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
